Headway is a private company building in healthcare (mental health / therapist-insurance marketplace). Its most recent disclosed valuation is $2.3B. Its shares do not trade on a public exchange.
2 valuations. The latest, $2.3B post-money, was set by the Series C in Oct 2023.
Spark CapitalLEAD
Andreessen HorowitzLEAD
GVSpark CapitalAndreessen HorowitzHeadway connects patients with more than 80,000 licensed therapists and psychiatrists who accept insurance, matching people with a provider online or in person. For therapists, Headway supplies free software that handles the paperwork of accepting insurance, and the company says two out of three providers on its platform can accept insurance because of it.
Headway is headquartered in the United States and describes its mission as building a new mental healthcare system that is simple to search and affordable to pay for with insurance. In October 2023 the company raised $125 million to expand this insurance-matching model.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Headway.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Headway availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Headway included.
The routes section explains what is realistically available for a company at this stage.
No. Headway is a private company; its shares do not trade on a public exchange.
The last valuation is $2.3B.
Lead investors for each round are in the funding timeline.
The closest healthcare (mental health / therapist-insurance marketplace) peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
